课题基金 / 基金详情

The mammalian target of rapamycin provides the female rodent heart sex-dependent resistance to ischemic damage

The mammalian target of rapamycin provides the female rodent heart sex-dependent resistance to ischemic damage
雷帕霉素的哺乳动物靶标为雌性啮齿动物心脏提供性别依赖性的缺血损伤抵抗力
批准号:
407781
负责人:
Calderone Angelo
金额:
$39.57万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2024-09-01

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been well established that the adult female heart has an inherently greater resistance to damage after a reduction of blood flow. Despite these findings, the underlying events providing the female heart greater protections remains equivocal. In add
期刊论文(0)
专著(0)
科研奖励(0)
会议论文